Prime Medicine PRME Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.63M+55.3% | $2.98M— | $0— | $0— | ||
| $160.64M+3.4% | $155.29M+5.0% | $147.91M+70.5% | $86.73M— | ||
| $52.35M+4.4% | $50.16M+15.6% | $43.39M+45.5% | $29.82M— | ||
| $212.98M+3.7% | $205.45M+0.3% | $204.79M+75.7% | $116.54M— | ||
| -$208.35M-2.9% | -$202.47M+1.1% | -$204.79M-75.7% | -$116.54M— | ||
| -4,498.1%+2,289pp | -6,787.4%— | —— | —— | ||
| $7.21M+9.5% | $6.59M+3.2% | $6.38M+202% | -$6.23M— | ||
| -$201.14M-2.7% | -$195.88M+1.1% | -$198.13M-62.6% | -$121.82M+26.3% | ||
| -4,342.4%+2,224pp | -6,566.6%— | —— | —— | ||
| -$1.37+17.0% | -$1.65+24.3% | -$2.18— | —— | ||
| -$201.03M-2.4% | -$196.34M+1.9% | -$200.14M-75.1% | -$114.32M— | ||
| -4,340%+2,242pp | -6,581.9%— | —— | —— | ||
| -$208.35M-2.9% | -$202.47M+1.1% | -$204.79M-75.7% | -$116.54M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Prime Medicine's revenue?
- Prime Medicine (PRME) generated $4.6M in revenue over the trailing twelve months, up 55.3% year over year.
- Is Prime Medicine profitable?
- Prime Medicine is not currently profitable: it reported a net loss of $198.4M over the trailing twelve months, a -4342.4% net margin.
- What is Prime Medicine's earnings per share?
- Prime Medicine's diluted EPS over the trailing twelve months is $-1.25.
- Where does Prime Medicine's income statement data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
